The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition. The post BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes appeared first on MedCity News.
Translucent AI raised $7 million in seed funding to help healthcare providers better manage mounting financial pressures. Its AI-powered platform is designed to give hospital leaders instant, plain-language answers to complex financial questions. The post Meet the Startup That’s like ChatGPT for Provider Finances appeared first on MedCity News.
Through a new tool, Blue Shield of California members can now be notified when a clinician begins an e-prescription and view lower-cost alternatives. The post Blue Shield of California Launches New Digital Tool for Medication Transparency appeared first on MedCity News.
The application of AI technology is part of a carefully orchestrated effort dependent on human intelligence, and the collaboration of physicians, disease-specific specialists, nurses, data scientists, and technologists. Done right, these efforts can lead to profound benefits, and offer a promising future for clinical research and patient care. The post Augmenting Brain Power: Real-World Data, Advanced…
Across the U.S., nearly 700 rural hospitals are at risk of closure. When they shut down, the impacts cascade: broken continuity, delayed care, and increased cyber risk in every new system a patient must navigate. The post The Hidden Fallout of Rural Hospital Closures: Patient Care Suffers – and So Does Data Security appeared first…
A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state. Although the state plans to appeal, one expert says the law likely has no future. The post Will the Arkansas PBM Law Survive A Judge’s Rejection? appeared first on MedCity News.
Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma. The drug came from Jazz’s $935 million acquisition of Chimerix earlier this year. The post Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug appeared first on MedCity News.
The Trump administration’s Make America Healthy Again nutrition policies and Medicare Advantage plan ethics were prominent themes on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and guest co-host Paul Markovich, CEO of Blue Shield of California parent company Ascendiun. The post Debunked Episode 18: Unpacking MAHA, Nutrition on a…
Centralized data aggregation is a necessity for homecare providers looking to address fragmentation, improve outcomes, and stay competitive in the rapidly evolving landscape. The path forward requires investment in tools that collect and transform data into actionable information. The post Centralized Data Aggregation in Homecare Powers Interoperability and Client-Centered Care appeared first on MedCity News.
[Sponsored] Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform. The post The Top Appointment Scheduling Software for Wellness Clinics appeared first on MedCity News.